Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways

Area of Science:

• Endocrinology
• Molecular Biology
• Pharmacology

Background:

• Glucocorticoids (GCs) are essential steroid hormones for maintaining tissue homeostasis and are widely used as anti-inflammatory drugs.
• GCs exert their effects via the glucocorticoid receptor (GR), a ligand-dependent transcription factor.
• GC resistance, a loss of efficacy, affects approximately 30% of patients, complicating treatment of inflammatory diseases and cancer.

Purpose of the Study:

• To explore mechanisms of GC resistance, particularly the role of mitogen-activated protein kinases (MAPKs) and dual-specific phosphatases (DUSPs).
• To discuss strategies for modulating GC responsiveness to overcome resistance and mitigate adverse effects.

Main Methods:

• Review of literature on GC signaling pathways, GR function, and mechanisms of GC resistance.
• Analysis of the interplay between GR, MAPKs, and DUSPs in the context of inflammation and GC efficacy.
• Discussion of potential therapeutic strategies targeting these pathways.

Main Results:

• GC resistance is often associated with excessive MAPK activation and altered DUSP expression.
• GCs' anti-inflammatory actions, including GR-mediated inhibition of MAPKs and induction of DUSPs, are compromised by MAPK pathway dysregulation.
• Imbalances in GC signaling can lead to tissue-specific effects and variable disease severity.

Conclusions:

• Understanding the mechanisms of GC resistance, particularly MAPK and DUSP involvement, is crucial for improving therapeutic outcomes.
• Targeting MAPK pathways and DUSP expression may offer strategies to restore GC sensitivity and reduce adverse effects.
• Modulating GC responsiveness holds potential for optimizing treatment of inflammatory conditions and cancer while minimizing side effects.